Recent decades have seen a plethora of regenerating new tissues in order to treat a multitude of cardiovascular diseases. Autografts, xenografts and bioengineered extracellular matrices have been employed in this endeavor. However, current limitations of xenografts and exogenous scaffolds to acquire sustainable cell viability, anti-inflammatory and non-cytotoxic effects with anti-thrombogenic properties underline the requirement for alternative bioengineered scaffolds.
View Article and Find Full Text PDFEpoxy resin composites with different weight fractions of TiO microparticles (1%, 5%, 10%, 15%, 20%) and of TiO nanoparticles (0.5%, 1%, 2%, 3%) were prepared. The particle size of the nanoparticles was averaged around 21 nm while the particle size of the micro TiO particles was averaged around 0.
View Article and Find Full Text PDF